NET CONNECT Update from ASCO, AACR and WCGIC 2020
NET CONNECT Update from ASCO, AACR and WCGIC 2020
Dr. Aman Chauhan
NET CONNECT has summarised highlights from ASCO 2020, AACR 2020 and WCGIC 2020 virtual meetings for you. Highlights from the abstracts: Efficacy and safety of surufatinib (ASCO), AGITG control NET Study (ASCO), DNA-PK inhibitor, M3814 (AACR) and Young adults with neuroendocrine tumours present high rate of pathogenic germline variants in cancer predisposing genes (WCGIC) by Dr. Aman Chauhan, University of Kentucky’s Markey Cancer Center, (NCI Designated Cancer Center), Kentucky, USA
Dr. Aman Chauhan
Medical Oncologist
University of Kentucky's Markey Cancer Centre
United States (US)
| 
10 min
|
Jul 2020
download resources
This programme was made for you: your opinion matters
Share your feedback in just 4 clicks and help us to continue to create the content you need.
I agree that this educational programme:
NET CONNECT is an initiative of COR2ED, supported by an Independent Educational Grant from Ipsen and from Eisai Europe Limited.
Other programmes of interest
28 min
Other programmes developed by Dr. Aman Chauhan
Dr. Aman Chauhan
Medical Oncologist
University of Kentucky's Markey Cancer Centre
United States (US)
